| | Board Recommends Final Dividend. | 02/05/22 18:02 | Company Update |  | | | The Board of Directors at its Meeting held on 2nd May, 2022 has recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e. Rs.1.50 (Rupee One and Paise Fifty) per Equity Share of Face Value of Rs.10/- (Rupees Ten Only) for the Financial Year ended 31st March, 2022, subject to approval of the Shareholders at the ensuing 28th (Twenty Eighth) Annual General Meeting of the Company. | | | | | | Announcement under Regulation 30 (LODR)-Dividend Updates | 02/05/22 17:50 | Corp Action | | | | Please find attached outcome of the Board Meeting held today i.e. on 2nd May, 2022. | | | | | | Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities & Exchange Board Of India(Listing Obligations And Disclosure Requirements) Regulations, 2015. | 02/05/22 17:45 | Corp. Action | | | | Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Thursday, 21st July, 2022 to Sunday, 24th July, 2022 (both days inclusive) for taking record of the Members of the Company for the purpose of the 28th (Twenty Eighth) Annual General Meeting and payment of Final Dividend. | | | | | | Corporate Action-Board approves Dividend | 02/05/22 17:29 | Corp. Action | | | | The Board of Directors at its Meeting held on 2nd May, 2022 has recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e. Rs.1.50 (Rupee One and Paise Fifty) per Equity Share of Face Value of Rs.10/- (Rupees Ten Only) for the Financial Year ended 31st March, 2022, subject to approval of the Shareholders at the ensuing 28th (Twenty Eighth) Annual General Meeting of the Company. | | | | | | Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended 31St March, 2022. | 02/05/22 17:19 | Result | | | | Please find attached outcome of the Board Meeting held today i.e. on 2nd May, 2022. | | | | | | Board Meeting Outcome for Outcome Of The Board Meeting. | 02/05/22 17:13 | Result | | | | Please find attached outcome of the Board Meeting held today i.e. on 2nd May, 2022. | | | | | | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | 30/04/22 13:43 | | | | | Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details | | 1 | Name of Compay | ASTEC LIFESCIENCES LIMITED | | 2 | CIN | L99999MH1994PLC076236 | | 3 | Outstanding borrowing of company as on 31st March / 31st December, as applicable .... | | | | | | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | 28/04/22 20:12 | Company Update | | | | Astec LifeSciences Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Conference Call to be held on Tuesday, May 3, 2022 at 3.30 p.m. | | | | | | Update on board meeting | 25/04/22 17:10 | Board Meeting | | | | ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2022 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), that the Meeting of the Board of Directors of Astec LifeSciences Limited ('the Company') is scheduled .... | | | | | | Board Meeting Intimation for Approval Of Standalone And Consolidated Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2022 And To Consider Recommendation Of Final Dividend, If Any, On The Equity Shares For The Financial Year Ended 31St March, 2022. | 25/04/22 15:08 | Board Meeting | | | | ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2022 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended 31st March, 2022 after these results are reviewed by the Audit Committee and to consider recommendation of Final Dividend, if any, on the Equity Shares of the Company for the Financial Year ended 31st March, 2022. | | | | | | Statement Of Investor Complaints For The Quarter Ended March 2022 | 19/04/22 17:12 | Company Update | | | | | No.of Investor complaints pending at the beginning of the quarter | No.of Investor complaints received during the quarter | No.of Investor complaints disposed of during the quarter | No.of Investor complaints unresolved at the end of the quarter |
|---|
| 0 | 0 | | | | | | | Certificate As Per Regulation 40(9) And 40(10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2022 | 18/04/22 23:49 | Company Update | | | | Please find enclosed herewith Certificate as per Regulation 40(9) and 40(10) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Financial Year ended 31st March, 2022. | | | | | | Compliance Certificate Under Regulation 7(3) Read With Regulation 7(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2022. | 18/04/22 16:04 | Company Update | | | | Please find attached, Compliance Certificate under Regulation 7(3) read with Regulation 7(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31st March, 2022. | | | | | | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | 18/04/22 15:03 | Company Update | | | | Please find enclosed herewith, compliance certificate received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of Astec LifeSciences Limited, for the Quarter ended 31st March, 2022, pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. | | | | | | Announcement under Regulation 30 (LODR)-Credit Rating | 08/04/22 19:47 | Company Update | | | | In continuation to our letter dated March 30, 2022 for intimating Credit Rating assigned/re-affirmed by ICRA Limited vide its letter dated March 29, 2022 and pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Regulations'), this is to inform you that ICRA Limited, vide its letter dated April 7, 2022, has re-affirmed 'ICRA A1+' .... | | | | | | Announcement under Regulation 30 (LODR)-Credit Rating | 30/03/22 18:24 | Company Update | | | | Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Regulations'), this is to inform you that ICRA Limited, vide its letter dated March 29, 2022, has:
Assigned 'ICRA A1+' rating (pronounced 'ICRA A one plus') to the enhanced Commercial Paper programme of Rs. 100 Crore (Rupees One Hundred Crore Only) of the Company; and
Re-affirmed .... | | | | | | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | 29/03/22 11:19 | Insider Trading / SAST | | | | The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashok V Hiremath | | | |
|
| |
Archives |
<< Previous | Next >>
|
|
<< Back To Announcements
|
|
|
|